Clinical Maestro founder Anca Copaescu says AI could help pharmaceutical companies identify contractor performance issues, financial risks and clinical trial problems earlier.
A deep neural decision forest model fuses convolutional feature extraction with differentiable decision trees to reach 98.5 ...
The Falcon-521CRS is an Onsemi AR0521 Color 5MP Low-Noise USB 3.2 Gen1 Camera, and Vadzo has validated its on-board ISP for ...
A prototype attendance system called Smart Click recognizes enrolled faces in group photographs with 95.26 percent accuracy, ...
Nei giorni scorsi Tesla, la società di Elon Musk che oltre alle auto produce anche i nuovi robotaxi Cybercab e i robot ...
Microsoft Research Asia (MSRA) unveiled research at "MSRA Korea Day 2026" on brain-computer interfaces (BCI) that read user intent from brainwaves ...
Dangote is deploying Honeywell's AI solution newly instaleld at its Nigerian oil refinery, while other companies such as Merck, Frito-Lay and BMW are using agentic tools to ...
Shifting models, pricing and expectations are wearing down workers and planners alike. Leaders say the fix is to build in ...
IDrive, Backblaze, Acronis and Veeam on price, ransomware recovery and restore options, with picks by use case.
Suzuki has lagged well behind most of its rivals in the introduction of hybrid and fully electric vehicles. At this [...] ...
The companies building AI are no longer just customers of infrastructure. They are beginning to become infrastructure companies themselves.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results